Table 1.
Subject demographics
| Placebo n = 8 |
0.25 mg/kg n = 5 |
0.50 mg/kg n = 5 |
0.75 mg/kg n = 5 |
1.00 mg/kg n = 5 |
1.25 mg/kg n = 5 |
1.50 mg/kg n = 5 |
1.75 mg/kg n = 5 |
2.00 mg/kg n = 5 |
||
|---|---|---|---|---|---|---|---|---|---|---|
| Number | 8 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | |
| Age, years | Mean ± SD | 69.0 ± 7.3 | 67.0 ± 8.8 | 65.2 ± 13.2 | 63.4 ± 8.1 | 55.0 ± 5.2 | 65.4 ± 8.3 | 65.8 ± 10.8 | 64.0 ± 6.4 | 67.4 ± 7.5 |
| Age | Min–max | 61–82 | 54–78 | 46–77 | 58–76 | 49–61 | 59–75 | 51–79 | 57–72 | 56–75 |
| Ethnicity / race | Hispanic | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| White | 7 (87.5) | 4 (80.0) | 4 (80.0) | 4 (80.0) | 3 (60.0) | 4 (80.0) | 3 (60.0) | 5 (100.0) | 3 (60.0) | |
| African | 1 (12.5) | 1 (20.0) | 1 (20.0) | 1 (20.0) | 2 (40.0) | 1 (20.0) | 2 (40.0) | 0 (0.0) | 2 (40.0) | |
| American | ||||||||||
| Sex | Male | 6 (75.0) | 5 (100.0) | 3 (60.0) | 5 (100.0) | 3 (60.0) | 3 (60.0) | 4 (80.0) | 3 (60.0) | 3 (60.0) |
| Female | 2 (25.0) | 0 (0.0) | 2 (40.0) | 0 (0.0) | 2 (40.0) | 2 (40.0) | 1 (20.0) | 2 (40.0) | 2 (40.0) | |
| Smoking status | None | 0 (0.0) | 1 (20.0) | 0 (0.0) | 1 (20.0) | 1 (20.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (20.0) |
| Former | 3 (37.5) | 2 (40.0) | 4 (80.0) | 0 (0.0) | 1 (20.0) | 3 (60.0) | 3 (60.0) | 2 (40.0) | 2 (40.0) | |
| Current | 5 (62.5) | 2 (40.0) | 1 (20.0) | 4 (80.0) | 3 (60.0) | 2 (40.0) | 2 (40.0) | 3 (60.0) | 2 (40.0) | |
| ABI | Mean ± SD | 0.65 ±0.14 | 0.80 ± 0.24 | 0.68 ± 0.32 | 0.57 ±0.17 | 0.67 ± 0.09 | 0.65 ±0.15 | 0.53 ±0.13 | 0.79 ± 0.08 | 0.55 ±0.17 |
ABI, ankle–brachial index.